臨牀消化器内科 Vol.21 No.6(8)


特集名 消化器癌の予防医学
題名 肝臓癌の化学予防
発刊年月 2006年 06月
著者 森脇 久隆 岐阜大学大学院医学系研究科消化器病態学
【 要旨 】 肝発癌には多段階発癌と多中心性発癌という二つの特徴がある.実際の高危険群は慢性肝炎 (からの初発),肝硬変 (からの初発),初発肝臓癌治療後の残存肝 (における再発) であり,それぞれ年間1 %,7 %,20 - 25 %の発癌率を示す.またこれらが肝発癌予防の対象病変となる.肝発癌予防は肝炎ウイルス対策,抗炎症療法,化学予防など総合戦略により行う.癌の化学予防は“to arrest or reverse premalignant cells by using physiological mechanisms”と定義されるアプローチであり,前癌細胞クローンを分化誘導あるいはアポトーシスにより除去する方策である (clonal deletion).肝臓癌化学予防の有力な候補薬剤にはレチノイドとビタミンKがあるが,いずれも使用可能となるまでにはさらに臨床試験が必要である.
Theme Preventive Medicine of Gastrointestinal Cancer
Title Chemoprevention of Liver Cancer
Author Hisataka Moriwaki Department of Gastroenterology, Gifu University Graduate School of Medicine
[ Summary ] Strategies to prevent liver carcinogenesis consists of : (1) antiviral modalities such as vaccination, lamivudin, and interferon, (2) anti-inflammatory modalities, and (3) chemoprevention, using such compounds as retinoid analogs and vitamin K. Cancer chemoprevention is defined as an approach where natural or synthetic chemical compounds work to arrest or reverse premalignant cells by employing physiological pathways. As a consequence, cloning of premalignant cells is eliminated (clonal deletion) by differentiation induction or apoptosis, and thus, the processes leading to the development of clinically detectable cancer are disrupted. A particularly effective candidate for chemoprevention in liver diseases is advanced chronic hepatitis, which is thought to contain transformed hepatocyte clone (s). Primary prevention from liver cirrhosis and prevention of recurrent and second primary hepatocellular carcinoma following the treatment of the initial cancer.
戻る